Prevalence and risk factors for colonization by extended-spectrum β-lactamase-producing or ST 131 Escherichia coli among asymptomatic adults in community settings in Southern Taiwan

References

• Karanika S, Karantanos T, Arvanitis M, Grigoras C, Mylonakis E. Fecal colonization with extended-spectrum beta-lactamase-producing enterobacteriaceae and risk factors among healthy individuals: a systematic review and metaanalysis. Clin Infect Dis. 2016;63(3):310–318. doi:10.1093/cid/ciw28327143671
   PubMed Web of Science ®Google Scholar
• Luvsansharav UO, Hirai I, Niki M, et al. Prevalence of fecal carriage of extended-spectrum beta-lactamase-producing Enterobacteriaceae among healthy adult people in Japan. J Infect Chemother. 2011;17(5):722–725. doi:10.1007/s10156-011-0225-221359543
   PubMed Web of Science ®Google Scholar
• Luvsansharav UO, Hirai I, Niki M, et al. Analysis of risk factors for a high prevalence of extended-spectrum {beta}-lactamase-producing Enterobacteriaceae in asymptomatic individuals in rural Thailand. J Med Microbiol. 2011;60(Pt 5):619–624. doi:10.1099/jmm.0.026955-021292857
   PubMed Web of Science ®Google Scholar
• Nicolas-Chanoine MH, Gruson C, Bialek-Davenet S, et al. 10-fold increase (2006–11) in the rate of healthy subjects with extended-spectrum beta-lactamase-producing Escherichia coli faecal carriage in a Parisian check-up centre. J Antimicrob Chemother. 2013;68(3):562–568. doi:10.1093/jac/dks42923143897
   PubMed Web of Science ®Google Scholar
• Ni Q, Tian Y, Zhang L, et al. Prevalence and quinolone resistance of fecal carriage of extended-spectrum beta-lactamase-producing Escherichia coli in 6 communities and 2 physical examination center populations in Shanghai, China. Diagn Microbiol Infect Dis. 2016;86(4):428–433. doi:10.1016/j.diagmicrobio.2016.07.01027681363
   PubMed Web of Science ®Google Scholar
• Ny S, Lofmark S, Borjesson S, et al. Community carriage of ESBL-producing Escherichia coli is associated with strains of low pathogenicity: a Swedish nationwide study. J Antimicrob Chemother. 2017;72(2):582–588. doi:10.1093/jac/dkw41927798205
   PubMed Web of Science ®Google Scholar
• Liu -Y-Y, Wang Y, Walsh TR, et al. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis. 2016;16(2):161–168.26603172
   PubMed Web of Science ®Google Scholar
• Lai CC, Chuang YC, Chen CC, Tang HJ. Coexistence of MCR-1 and NDM-9 in a clinical carbapenem-resistant Escherichia coli isolate. Int J Antimicrob Agents. 2017;49(4):517–518.28219753
   PubMed Web of Science ®Google Scholar
• Krishnan E, Akhras KS, Sharma H, et al. Relative and attributable diabetes risk associated with hyperuricemia in US veterans with gout. Qjm. 2013;106(8):721–729.23620537
   PubMed Web of Science ®Google Scholar
• Chia JH, Chu C, Su LH, et al. Development of a multiplex PCR and SHV melting-curve mutation detection system for detection of some SHV and CTX-M beta-lactamases of Escherichia coli, Klebsiella pneumoniae, and Enterobacter cloacae in Taiwan. J Clin Microbiol. 2005;43(9):4486–4491. doi:10.1128/JCM.43.9.4486-4491.200516145096
   PubMed Web of Science ®Google Scholar
• Sidjabat HE, Paterson DL, Adams-Haduch JM, et al. Molecular epidemiology of CTX-M-producing Escherichia coli isolates at a tertiary medical center in western Pennsylvania. Antimicrob Agents Chemother. 2009;53(11):4733–4739. doi:10.1128/AAC.00533-0919687234
   PubMed Web of Science ®Google Scholar
• Dallenne C, Da Costa A, Decre D, Favier C, Arlet G. Development of a set of multiplex PCR assays for the detection of genes encoding important beta-lactamases in Enterobacteriaceae. J Antimicrob Chemother. 2010;65(3):490–495. doi:10.1093/jac/dkp49820071363
   PubMed Web of Science ®Google Scholar
• Belmar Campos C, Fenner I, Wiese N, et al. Prevalence and genotypes of extended spectrum beta-lactamases in Enterobacteriaceae isolated from human stool and chicken meat in Hamburg, Germany. Int J Med Microbiol. 2014;304(5–6):678–684. doi:10.1016/j.ijmm.2014.04.01224856867
   PubMed Web of Science ®Google Scholar
• Doumith M, Day M, Ciesielczuk H, et al. Rapid identification of major Escherichia coli sequence types causing urinary tract and bloodstream infections. J Clin Microbiol. 2015;53(1):160–166. doi:10.1128/JCM.02562-1425355761
   PubMed Web of Science ®Google Scholar
• Lai CC, Lin YT, Lin YT, et al. Clinical characteristics of patients with bacteraemia due to the emergence of mcr-1-harbouring Enterobacteriaceae in humans and pigs in Taiwan. Int J Antimicrob Agents. 2018;52(5):651–657. doi:10.1016/j.ijantimicag.2018.08.01530145246
   PubMed Web of Science ®Google Scholar
• Chung HC, Lai CH, Lin JN, et al. Bacteremia caused by extended-spectrum-beta-lactamase-producing Escherichia coli sequence type ST131 and non-ST131 clones: comparison of demographic data, clinical features, and mortality. Antimicrob Agents Chemother. 2012;56(2):618–622. doi:10.1128/AAC.05753-1122123694
   PubMed Web of Science ®Google Scholar
• Jean B, Mpw P, Eliopoulos GM, Jenkins SG. M100 Performance Standards for Antimicrobial Susceptibility Testing. 27th ed. Wayne, Pennsylvania, USA: Clinical and Laboratory Standards Institute; 2017.
   Google Scholar
• D BP S, Grimmelprez A, de Saint-Hubert M, et al. Clinical profiles of patients colonized or infected with extended-spectrum beta-lactamase producing Enterobacteriaceae isolates: a 20 month retrospective study at a Belgian University Hospital. BMC Infect Dis. 2011Jan12;11:12. doi:10.1186/1471-2334-11-12
   Web of Science ®Google Scholar
• Johnson JR, Thuras P, Johnston BD, et al. The pandemic H30 subclone of Escherichia coli sequence type 131 is associated with persistent infections and adverse outcomes independent from its multidrug resistance and associations with compromised hosts. Clin Infect Dis. 2016;62(12):1529–1536. doi:10.1093/cid/ciw19327025834
   PubMed Web of Science ®Google Scholar
• Peters BA, Dominianni C, Shapiro JA, et al. The gut microbiota in conventional and serrated precursors of colorectal cancer. Microbiome. 2016;4(1):69. doi:10.1186/s40168-016-0218-628038683
   PubMed Web of Science ®Google Scholar
• Oteo J, Pérez-Vázquez M, Extended-Spectrum CJ. β-lactamase producing Escherichia coli: changing epidemiology and clinical impact. Curr Opin Infect Dis. 2010;23(4):320–326.20614578
   PubMed Web of Science ®Google Scholar
• PL AC W, Jacquier H, Clermont O, et al. Characterization of fecal extended-spectrum-β-lactamase-producing Escherichia coli in a remote community during a long time period. Antimicrob Agents Chemother. 2013;57(10):5060–5066. doi:10.1128/AAC.00848-1323917313
   PubMed Web of Science ®Google Scholar
• Woerther PL, Andremont A, Kantele A. Travel-acquired ESBL-producing Enterobacteriaceae: impact of colonization at individual and community level. J Travel Med. 2017;24(suppl_1):S29–S34. doi:10.1093/jtm/taw10128520999
   PubMed Web of Science ®Google Scholar
• Johnson JR, Johnston B, Clabots C, Kuskowski MA, Castanheira M. Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States. Clin Infect Dis. 2010;51(3):286–294. doi:10.1086/65393220572763
   PubMed Web of Science ®Google Scholar
• Torres E, Lopez-Cerero L, Morales I, Navarro MD, Rodriguez-Bano J, Pascual A. Prevalence and transmission dynamics of Escherichia coli ST131 among contacts of infected community and hospitalized patients. Clin Microbiol Infect. 2018;24(6):618–623. doi:10.1016/j.cmi.2017.09.00728939488
   PubMed Web of Science ®Google Scholar
• Ha YE, Kang CI, Cha MK, et al. Epidemiology and clinical outcomes of bloodstream infections caused by extended-spectrum beta-lactamase-producing Escherichia coli in patients with cancer. Int J Antimicrob Agents. 2013;42(5):403–409. doi:10.1016/j.ijantimicag.2013.07.01824071027
   PubMed Web of Science ®Google Scholar
• Johnson JR, Nicolas-Chanoine MH, DebRoy C, et al. Comparison of Escherichia coli ST131 pulsotypes, by epidemiologic traits, 1967–2009. Emerg Infect Dis. 2012;18(4):598–607. doi:10.3201/eid1804.11162722469129
   PubMed Web of Science ®Google Scholar
• M MA C-L, López C, Mamani R, et al. Detection of quinolone-resistant Escherichia coli isolates belonging to clonal groups O25b: H4-B2-ST131and O25b: H4-D-ST69in raw sewage and river water in Barcelona, Spain. J Antimicrob Chemother. 2013;68(4):758–765. doi:10.1093/jac/dks47723221627
   PubMed Web of Science ®Google Scholar
• SC HW K, Wang HY, Shiau YR, Cheng MF, Lauderdale TL. Colistin resistance gene mcr-1 in Escherichia coli isolates from humans and retail meats, Taiwan. J Antimicrob Chemother. 2016;71(8):2327–2329. doi:10.1093/jac/dkw12227076107
   PubMed Web of Science ®Google Scholar
• CS CY C, Wang YW, Liu YY, et al. Dissemination of mcr-1-carrying plasmids among colistin-resistant salmonella strains from humans and food-producing animals in Taiwan. Antimicrob Agents Chemother. 2017;61:7.
   Web of Science ®Google Scholar
• Pham Thanh D, Thanh Tuyen H, Nguyen Thi Nguyen T, et al. Inducible colistin resistance via a disrupted plasmid-bornemcr-1gene in a 2008 VietnameseShigella sonneiisolate. J Antimicrob Chemother. 2016;71(8):2314–2317. doi:10.1093/jac/dkw17327246235
   PubMed Web of Science ®Google Scholar
• Terveer EM, Nijhuis RHT, Crobach MJT, et al. Prevalence of colistin resistance gene (mcr-1) containing Enterobacteriaceae in feces of patients attending a tertiary care hospital and detection of a mcr-1 containing, colistin susceptible E. coli. PLoS One. 2017;12(6):e0178598. doi:10.1371/journal.pone.017859828575076
   PubMed Web of Science ®Google Scholar
• Bi Z, Berglund B, Sun Q, et al. Prevalence of the mcr-1 colistin resistance gene in extended-spectrum beta-lactamase-producing Escherichia coli from human faecal samples collected in 2012 in rural villages in Shandong Province, China. Int J Antimicrob Agents. 2017;49(4):493–497. doi:10.1016/j.ijantimicag.2016.12.01828263896
   PubMed Web of Science ®Google Scholar
• Chan WS, Au CH, Ho DN, Chan TL, Ma ES, Tang BS. Prospective study on human fecal carriage of Enterobacteriaceae possessing mcr-1 and mcr-2 genes in a regional hospital in Hong Kong. BMC Infect Dis. 2018;18(1):81. doi:10.1186/s12879-018-3109-629439654
   PubMed Web of Science ®Google Scholar